Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_assertion type Assertion NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_head.
- NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_assertion wasGeneratedBy ECO_0000203 NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_provenance.
- NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_assertion wasDerivedFrom befree-20150227 NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_provenance.
- NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_assertion SIO_000772 22525818 NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_provenance.
- NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_assertion evidence source_evidence_literature NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_provenance.
- NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_assertion description "[Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995529.RAClxYDeCesa4k8jNMEUxyaInRoJJpT0zxTEhcg2KjyG0130_provenance.